Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesEffect of Corrective Surgery on Neurocognitive Functions in Endogenous Cushing Syndrome
The Endocrinologist, 09/16/09
Nehra R et al. – Correlation analysis showed that deficits in attention and concentration were greater in subjects with higher preoperative cortisol levels. From this study it can be concluded that subjects with Cushing syndrome suffer from neurocognitive deficits which improve with correction of cortisol levels.
Related Articles
Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09
Relevance Score: 90%
Biochemical Predictors of Outcome of Pituitary Surgery for Cushing's Disease
Neuroendocrinology, 11/12/09
Relevance Score: 87%
ACTH-producing pheochromocytoma: Clinical considerations and concise review of the literature
European Journal of Internal Medicine, 10/12/09
Relevance Score: 81%
Isolated Cushing's Syndrome: An Unusual Presentation of McCune-Albright Syndrome in the Neonatal Period
Hormone Research, 10/27/09
Relevance Score: 69%
Hypertrophic Remodeling of Subcutaneous Small Resistance Arteries in Patients with Cushing's Syndrome
Journal of Clinical Endocrinology and Metabolism, 11/11/09
Relevance Score: 66%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of the Perifornical Hypothalamic Monoamine Neurotransmitter Systems in Anorectic Effects of Endotoxin
Neuroendocrinology, 12/01/09
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Sponsor
Article Search
Sponsor